European Pharmaceutical Review

AUGUST 24, 2022

The antibody is chosen based on its high selectivity and affinity for the tumour-associated antigen and its ability to facilitate internalisation or endocytosis, wherein molecules such as proteins are engulfed by the cell membrane and drawn into the cell. Fu Z, Li S, Han S, et al. Zacharias N, Podust V, Kajihara K, et al.

Compounding 82

Compounding Pharmaceutical Companies Pharmaceutical Companies 82

Pharmaceutical Technology

JUNE 29, 2022

The US Food and Drug Administration (FDA) put a high-profile bluebird bio trial for sickle cell disease on partial clinical hold, and advisory panels deliberated over decisions involving gene therapies for amyotrophic lateral sclerosis (ALS), cerebral adrenoleukodystrophy (CALD), and beta-thalassemia.

Pharmaceutical Companies 98

Pharmaceutical Companies Pharmaceutical Companies FDA 98

PharmaShots

MARCH 9, 2023

She has also been appointed as the president of the American Pancreas Association (APA). An elected member of Association of American Physicians (AAP) and the American Society for Clinical Investigation (ASCI), she also serves fellow of the American Gastroenterological Association. LinkedIn Total experience: 26 yrs.

FDA 40

FDA Pharmaceutical Companies Pharmaceutical Companies Immunization 40

European Pharmaceutical Review

DECEMBER 27, 2023

This is especially important due to the two unique toxicities of CAR T cells, namely CRS and the neurology toxicities that subsequently received the term immune effector cell- associated neurotoxicity syndrome (ICANS). This is in addition to its considerable price tag. Grupp SA, Kalos M, Barrett D, et al. Asghar N, et al.

Adverse Reactions 83

Adverse Reactions Immunization Medical Schools Chemotherapy 83